FDA Blesses Ziopharm Cancer Drug

forbes.com     May 9, 2008            

The Orphan Drug Act gives pharma companies an extra incentive to work on smaller-market drugs. ... Sometimes, not very often, companies do things that they know won't make them a lot of money, but that will be good for at least a small group of people. Ziopharm Oncology... [read full story]                

Add a comment to the article
Type the code shown

View all news articles about:

- Related Topics